In 2026, pharmacy rebate offerings are evolving, prompting plans to take a closer look at how rebates are structured and delivered. In this webinar, Truveris pharmacy experts will break down how rebates flow today, what PBM rebate offers currently look like, and how market dynamics are shifting. We’ll explore emerging structures such as per-claim guarantees, rebate credits tied to insulin, biosimilars, and IRA provisions, and the growing role of point of sale and pass-through models.
We’ll also examine the migration towards drug-level rebate offers, what they mean for plan sponsors, and how major PBMs are responding. Attendees will leave with a clearer understanding of where the rebate landscape is heading and how to evaluate rebate strategies in 2026 and beyond.
Learning Objectives
- Understand how pharmacy rebate offerings are evolving: Gain clarity on how rebates flow today, the types of PBM rebate offers currently in market, and how plan sponsors are rethinking rebate structures.
- Evaluate the shift toward drug-level and alternative rebate structures: Examine the migration toward drug level rebate offers during procurement, the growing use of point of sale (POS) and pass through rebate models, and what these changes mean for plan sponsor decision making and PBM contract evaluation.
- Assess how major PBMs and regulatory activity influence rebate strategies: Understand how leading PBMs are responding to changing plan preferences, including new and upcoming offerings, and assess the potential implications of FTC activity and other market developments on rebate strategies in 2026.
About the Speakers:
Sarah Berry, PharmD, Clinical Director
Sarah Berry, Clinical Director at Truveris, brings more than twelve years of experience in pharmacy benefit management, procurement strategy, and plan optimization. Sarah holds a Doctor of Pharmacy degree from the University of South Carolina–Columbia.
Timothy Downey-Zayas, Senior Director of Analytics
Timothy Downey-Zayas, Senior Director of Analytics at Truveris, has spent his entire career in healthcare, beginning in clinical research at Memorial Sloan Kettering before transitioning into pharmacy benefits. After starting at Truveris as an analyst specializing in PBM contract oversight and reconciliation, Tim now leads the analytics team, bringing nearly a decade of experience in pharmacy benefits oversight to drive data-informed value for clients.
Truveris is a pharmacy cost containment company dedicated to reducing pharmacy costs and driving transparency for employers and benefit consultants. Our proprietary, data-driven technology and deep industry expertise empower smarter pharmacy benefit decisions through contract optimization and PBM oversight. Independent and unbiased, Truveris delivers measurable savings and accountability across every pharmacy program.
